Kenzo Kurosawa

Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease

H. Tomioka, K. Konishi, K. Hori, 2015, Neurodegenerative Diseases.

Demonstrating the Role of Anticholinergic Activity in a Mood Disorder

H. Tomioka, K. Konishi, K. Hori, 2015, Neurodegenerative Diseases.

A Clinical Pharmacological Study to Evaluate the Sedative Effects of the Histamin 111 Antagonist, Diphenhydramine Hydrochloride (Drewell ®), in Healthy Male Elderly Subjects

Kazuhiro Matsuda, S. Ishigaki, N. Uchida, 2006 .

Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity

H. Tomioka, K. Konishi, K. Hori, 2015, Neurodegenerative Diseases.

A Clinical Pharmacological Study to Evaluate the Sedative Effects of the Antihistaminic Drug, Diphenhydramine Hydrochloride (Drewell®)

S. Ishigaki, N. Uchida, M. Iwase, 2006 .

Sigma-1 receptor concentration in plasma of patients with late-life depression: a preliminary study

A. Iwanami, M. Mimura, H. Yamada, 2013, Neuropsychiatric disease and treatment.

PM528. The key factor in reducing prevalence of cardiovascular disease and metabolic syndrome among Japanese chronic schizophrenia

A. Iwanami, O. Takashio, Atsuko Inamoto, 2016, International Journal of Neuropsychopharmacology.